GMPs Applied to Medical Cannabis: All You Need to Know
OVERVIEW
When we discuss growing, producing,
and manufacturing medical cannabis, we must think of it as a medicine. Medicine
by definition, it is a substance intended to assist you with a medical
condition, to help you feel better and not harm you. Drugs produced in the
pharmaceutical industry go through extensive quality controls to ensure a level
of safety for the consumer or patient. Yet when we talk process and quality
controls in medical cannabis production, there is still a lot to learn.
With all new events the FDA has stated that it “recognizes the significant
public interest in cannabis and cannabis-derived compounds, particularly CBD.”
However, there are many unanswered questions about the science, safety, and
quality of products containing CBD.
The agency is working on answering these questions through ongoing efforts
including feedback from a recent FDA hearing and information and data gathering
through a public docket. In order to start understanding what it means for GMP
regulated industries, we will discuss what we need to know, for now.
WHY SHOULD YOU ATTEND
Attend the webinar to learn what the
regulations say about medical cannabis, including GMP guidelines for
pharmaceuticals, cannabis quality control regulations and more.
AREAS COVERED
• Current events associated to
cannabis
• FDA, CANADA, and Europe regulations and standards
• What does it mean for drug manufacturing sites?
• Application from Pharma to Cannabis
• Our role from GMP standpoint
• Industry crossover
LEARNING OBJECTIVES
• Recent federal government
position on ending Cannabis prohibition nationwide
• FDA position on CBD and other cannabis derived products
• Background from a regulatory standpoint
• GMP guidelines for pharmaceuticals
• Approvals by states and what have we learned
• Challenges with the regulation of plant-based product
• Dosage challenges
• HR policies and the new cannabis era (labor laws challenges)
• Common quality failures and threats, and cannabis quality control
regulations
• Prepare for what’s next in GMP compliance
WHO WILL BENEFIT
• Training managers and
coordinators
• Operations
• Manufacturing
• Plant engineering
• QA/QC staff
• Process excellence/improvement professionals
• Industrial/process engineers
• Compliance officers
• Regulatory/legislative affairs professionals
• General/corporate counsel
SPEAKER
Years of Experience: 23+
years
Areas of Expertise: Engineering
Psychology and Human Reliability
Ginette Collazo, Ph. D. is an Industrial-Organizational
Psychologist with 20 years of experience that specializes in Engineering
Psychology and Human Reliability, disciplines that study the interaction
between human behavior and productivity. She has held positions leading
training and human reliability programs in the Pharmaceutical and Medical
Device Manufacturing Industry.
Ten years ago, Dr. Collazo
established Human Error Solutions (HES), a Florida based boutique
consulting firm, where she has been able to position herself as one of the few
Human Error Reduction Experts in the world. HES, led by Dr. Collazo,
developed a unique methodology for human error investigations, cause
determination, CA-PA development and effectiveness that has been implemented
and proven amongst different industries globally. This scientific method has
been applied in critical quality situations and workplace accidents.
To Register (or) for more details please click on this below link:
Email: support@trainingdoyens.com
Toll Free: +1-888-300-8494
Tel: +1-720-996-1616
Fax: +1-888-909-1882
Comments
Post a Comment